Though the FDA has said it will approve more generic drugs as a strategy to increase competition and combat drug shortages, a study published by JAMA Network Open found that the number of generic approvals has remained steady.

Merck plans to use a cloud-based software platform to better predict and prevent drug shortages, according to The Wall Street Journal.

A survey released Oct. 15 by healthcare legal and consulting group Manatt Health details how the 340B Drug Pricing Program works alongside Medicaid in all 50 states.

A Swiss newspaper reported that the U.S. is considering placing tariffs on exports of pharmaceutical goods from Switzerland, according to Endpoints News. 

A critical chemotherapy medication that serves is a primary treatment for most childhood cancers has become increasingly scarce, according to The New York Times.

In the third quarter of 2019, 125 drugs increased in price by an average of 6.7 percent, according to a new quarterly report from drug savings website GoodRx.

 A U.S. bankruptcy judge on Oct. 11 temporarily halted civil lawsuits against Purdue Pharma and the Sackler family, according to The Washington Post. 

The drug-pricing bill proposed by House Speaker Nancy Pelosi, D-Calif., could save Medicare up to $345 billion over seven years, according to a new estimate by the Congressional Budget Office. 

New York City-based NYC Health + Hospitals is looking to enter a new 340B contract expected to save the system $156.8 million in three years, according to Politico. 

If elected, several Democratic presidential candidates said they will invoke a law that would allow the president to lower drug prices without congressional approval, according to The Hill.